Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-1991 | 09-1990 | |
| Sales | 18 | 18 |
| Cost of Goods | 4 | 4 |
| Gross Profit | 14 | 14 |
| Operating Expenses | 218 | 218 |
| Operating Income | -200 | -200 |
| Interest Expense | 1 | 1 |
| Other Income | 2 | 2 |
| Pre-tax Income | -199 | -199 |
| Income Tax | -2 | -2 |
| Net Income Continuous | -198 | -198 |
| Net Income | $-198 | $-198 |
| EPS Basic Total Ops | -395.40 | -395.40 |
| EPS Basic Continuous Ops | -395.60 | -395.60 |
| EPS Diluted Total Ops | -395.40 | -395.40 |
| EPS Diluted Continuous Ops | -395.60 | -395.60 |
| EBITDA(a) | $-178 | $-200 |